Reference
1. Houben RM, Dodd PJ. The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling. PLoS medicine 2016; 13: e1002152.
2. Lee MR, Ho CM, Lee CH, Lee MC, Chang LY, Yu KL, Ko JC, Wang JY, Wang JT, Lee LN. Tuberculosis contact investigation in an intermediate burden setting: implications from a large tuberculosis contact cohort in Taiwan. The European respiratory journal 2017; 50.
3. Lee C-H, Wang J-Y, Lin H-C, Lin P-Y, Chang J-H, Suk C-W, Lee L-N, Lan C-C, Bai K-J. Treatment delay and fatal outcomes of pulmonary tuberculosis in advanced age: a retrospective nationwide cohort study. BMC infectious diseases 2017; 17: 449.
4. Yee D, Valiquette C, Pelletier M, Parisien I, Rocher I, Menzies D. Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis. American journal of respiratory and critical care medicine 2003; 167: 1472-7.
5. Forget EJ, Menzies D. Adverse reactions to first-line antituberculosis drugs. Expert opinion on drug safety 2006; 5: 231-49.
6. Lin Y-Y, Huang C-S. Aging in Taiwan: Building a Society for Active Aging and Aging in Place. The Gerontologist 2015; 56: 176-83.
7. Awofeso N. Anti-tuberculosis medication side-effects constitute major factor for poor adherence to tuberculosis treatment. Bulletin of the World Health Organization 2008; 86: B-d.
8. De Vriese AS, Robbrecht DL, Vanholder RC, Vogelaers DP, Lameire NH. Rifampicin-associated acute renal failure: pathophysiologic, immunologic, and clinical features. American journal of kidney diseases : the official journal of the National Kidney Foundation 1998; 31: 108-15.
9. Kumar S, Mehta JA, Trivedi HL. Light-chain proteinuria and reversible renal failure in rifampin-treated patients with tuberculosis. Chest 1976; 70: 564-5.
10. Winter RJ, Banks RA, Collins CM, Hoffbrand BI. Rifampicin induced light chain proteinuria and renal failure. Thorax 1984; 39: 952-3.
11. Kwon SH, Kim JH, Yang JO, Lee EY, Hong SY. Ethambutol-induced acute renal failure. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004; 19: 1335-6.
12. Trainin EB, Turin RD, Gomez-Leon G. Acute renal insufficiency complicating isoniazid therapy. The International journal of pediatric nephrology 1981; 2: 53-4.
13. Covic A, Goldsmith DJ, Segall L, Stoicescu C, Lungu S, Volovat C, Covic M. Rifampicin-induced acute renal failure: a series of 60 patients. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1998; 13: 924-9.
14. Chang CH, Chen YF, Wu VC, Shu CC, Lee CH, Wang JY, Lee LN, Yu CJ. Acute kidney injury due to anti-tuberculosis drugs: a five-year experience in an aging population. BMC infectious diseases 2014; 14: 23.
15. Schubert C, Bates WD, Moosa MR. Acute tubulointerstitial nephritis related to antituberculous drug therapy. Clinical nephrology 2010; 73: 413-9.
16. Muthukumar T, Jayakumar M, Fernando EM, Muthusethupathi MA. Acute renal failure due to rifampicin: a study of 25 patients. American journal of kidney diseases : the official journal of the National Kidney Foundation 2002; 40: 690-6.
17. Centers for Disease Control MoHaW, R.O.C.(Taiwan). Taiwan Guidelines for TB Diagnosis & Treatment (6E). 2017.
18. Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clinical practice 2012; 120: c179-84.
19. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Annals of internal medicine 2006; 145: 247-54.
20. O’Sullivan ED, Hughes J, Ferenbach DA. Renal Aging: Causes and Consequences. Journal of the American Society of Nephrology 2017; 28: 407-20.
21. Coca SG. Acute kidney injury in elderly persons. American journal of kidney diseases : the official journal of the National Kidney Foundation 2010; 56: 122-31.
22. Finlay S, Bray B, Lewington AJ, Hunter-Rowe CT, Banerjee A, Atkinson JM, Jones MC. Identification of risk factors associated with acute kidney injury in patients admitted to acute medical units. Clinical medicine (London, England) 2013; 13: 233-8.
23. Cheng Y, Luo R, Wang X, Wang K, Zhang N, Zhang M, Wang Z, Dong L, Li J, Zeng R, Yao Y, Ge S, Xu G. The Incidence, Risk Factors, and Prognosis of Acute Kidney Injury in Adult Patients with Coronavirus Disease 2019. Clinical Journal of the American Society of Nephrology 2020; 15: 1394-402.
24. Kellum JA, Romagnani P, Ashuntantang G, Ronco C, Zarbock A, Anders H-J. Acute kidney injury. Nature Reviews Disease Primers 2021; 7: 52.
25. Waikar SS, Bonventre JV. Creatinine kinetics and the definition of acute kidney injury. Journal of the American Society of Nephrology : JASN 2009; 20: 672-9.
26. Perazella MA, Rosner MH. Drug-Induced Acute Kidney Injury. Clinical Journal of the American Society of Nephrology 2022: CJN.11290821.
27. Muriithi AK, Nasr SH, Leung N. Utility of Urine Eosinophils in the Diagnosis of Acute Interstitial Nephritis. Clinical Journal of the American Society of Nephrology 2013; 8: 1857-62.
28. Perazella MA. AKI in a hospitalized patient with cellulitis. Clinical journal of the American Society of Nephrology : CJASN 2013; 8: 658-64.
29. Perazella MA, Markowitz GS. Drug-induced acute interstitial nephritis. Nature reviews Nephrology 2010; 6: 461-70.
30. Matz J, Borish LC, Routes JM, Rosenwasser LJ. Oral desensitization to rifampin and ethambutol in mycobacterial disease. American journal of respiratory and critical care medicine 1994; 149: 815-7.
31. Kim JH, Kim HB, Kim BS, Hong SJ. Rapid oral desensitization to isoniazid, rifampin, and ethambutol. Allergy 2003; 58: 540-1.
Table 1. Patient characteristics, stratified by status of acute kidney injury (AKI)